Aevitas Wealth Management, Inc. Iveric Bio, Inc. Transaction History
Aevitas Wealth Management, Inc.
- $169 Million
- Q4 2022
A detailed history of Aevitas Wealth Management, Inc. transactions in Iveric Bio, Inc. stock. As of the latest transaction made, Aevitas Wealth Management, Inc. holds 17,773 shares of ISEE stock, worth $0. This represents 0.22% of its overall portfolio holdings.
Number of Shares
17,773
Previous 17,673
0.57%
Holding current value
$0
Previous $317,000
19.87%
% of portfolio
0.22%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding ISEE
# of Institutions
7Shares Held
250KCall Options Held
40KPut Options Held
0-
Monarch Partners Asset Management LLC187KShares$01.22% of portfolio
-
Pictet Asset Management Sa Geneva 73, V825KShares$00.0% of portfolio
-
Jefferies Group LLC New York, NY19.5KShares$00.0% of portfolio
-
Endurance Wealth Management, Inc.1.5KShares$00.01% of portfolio
-
Wipfli Financial Advisors Llc,39Shares$00.0% of portfolio
About IVERIC bio, Inc.
- Ticker ISEE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,078,000
- Description
- IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...